Edwards Lifesciences Narrows FY2026 Sales Guidance from $6.600B-$6.900B to $6.766B vs $6.767B Est
Benzinga Newsdesk 2 weeks ago
NewsGuidanceHot
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Edwards Lifesciences (NYSE:EW) narrows FY2026 sales outlook from $6.600 billion-$6.900 billion to $6.766 billion vs $6.767 billion estimate.
Edwards Lifesciences (NYSE:EW) narrows FY2026 sales outlook from $6.600 billion-$6.900 billion to $6.766 billion vs $6.767 billion estimate.
